Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 11, Number 2—February 2005

Dispatch

In Vitro Host-Cell Susceptibility to Usutu Virus

Tamás Bakonyi*†, Helga Lussy*, Herbert Weissenböck*, Ákos Hornyák†‡, and Norbert Nowotny*§Comments to Author 
Author affiliations: *University of Veterinary Medicine, Vienna, Austria; †Faculty of Veterinary Science, Budapest, Hungary; ‡Central Veterinary Institute, Budapest, Hungary; §United Arab Emirates University, Al Ain, United Arab Emirates

Main Article

Figure 2

Demonstration of Usutu virus antigen 3 days postinfection. Immunohistochemical (IHC) tests were performed by using a polyclonal antibody to West Nile virus, which cross-reacts with Usutu virus. A) Vero control; B) Vero infected; C) CR (feline) control; D) CR infected; E) goose embryo fibroblast (GEF) control; F) GEF infected; A,B) bar = 50 μm; C–F) bar = 100 μm. †3 days postinfection (p.i.), IHC staining.

Figure 2. Demonstration of Usutu virus antigen 3 days postinfection. Immunohistochemical (IHC) tests were performed by using a polyclonal antibody to West Nile virus, which cross-reacts with Usutu virus. A) Vero control; B) Vero infected; C) CR (feline) control; D) CR infected; E) goose embryo fibroblast (GEF) control; F) GEF infected; A,B) bar = 50 μm; C–F) bar = 100 μm. †3 days postinfection (p.i.), IHC staining.

Main Article

1This study will be presented at the International Conference on Emerging Infectious Diseases, February 26–March 3, 2005, Al Ain, United Arab Emirates

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO